Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (14223)	2/4/1998 2:24:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

There never has been, nor will there be any 'gloating' on my part. Read into my posts whatever you will, however, unless you point to a post of mine where you state that I 'gloat', I will take the lack of such to be a retraction of your statement. --Tony

To: Flagrante Delictu who wrote (14223)	2/4/1998 2:47:00 PM
From: buyhiman	Read Replies (2) \| Respond to of 32384

Does anyone know if LGND is expected to be on target with NDA submissions; as I recall there was hope for filings by 1Q98. Also, does anyone know if any non-U.S. filings (PLA's) are planned or already submitted? If anything will spark interest and stock price moves it will be the filings ( a major milestone) and the status/priority level of the FDA review. The warrants (and stock) will be plenty attractive if PLA's are submitted soon and put on a fast track at the FDA (as innovative or improved therapies addressing and unmet need). Carl R.